Literature DB >> 17430346

Differences in the composition of intestinal Bifidobacterium species and the development of allergic diseases in infants in rural Japan.

S Suzuki1, N Shimojo, Y Tajiri, M Kumemura, Y Kohno.   

Abstract

BACKGROUND: Bifidobacterium is a dominant genus in the intestinal microbiota of infants and comprises many different species. A series of studies performed in northern Europe showed differences in the composition of Bifidobacterium species between allergic infants and healthy controls. Additional studies are needed to confirm this observation.
OBJECTIVE: To investigate the composition of fecal Bifidobacterium species in allergic infants and healthy controls in Japan, using molecular methods.
METHODS: Full-term born babies were followed up to 6 months of age at a local hospital in rural Japan. The presence or absence of allergy was determined based on allergic symptoms and skin prick tests. Fecal Bifidobacterium species in allergic infants (n=10), and healthy controls (n=16) were evaluated using nine Bifidobacterium species-specific or group-specific primers based on 16S rDNA sequences at 1, 3, and 6 months of age.
RESULTS: The number of the infants in whom no Bifidobacterium species could be found was four (15.4%) at 1 month, two (7.7%) at 3 months, and one (3.3%) at 6 months of age, all of whom were healthy controls. At 1 month of age, allergic infants had a higher prevalence f the Bifidobacterium catenulatum group than healthy controls (60.0% vs. 6.3%, P<0.01). At 6 months of age, allergic infants had a higher prevalence of B. bifidum than healthy controls (70.0% vs. 12.5%, P<0.01). These differences were not related to feeding method.
CONCLUSIONS: Our results in infants in rural Japan support the hypothesis that a compositional difference in intestinal Bifidobacterium species may be associated with the development of allergy in early infancy, although the responsible species might vary among countries or races.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17430346     DOI: 10.1111/j.1365-2222.2007.02676.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  15 in total

1.  Qualitative and Semiquantitative Analysis of Fecal Bifidobacterium Species in Centenarians Living in Bama, Guangxi, China.

Authors:  Fang Wang; Guohong Huang; Da Cai; Danlei Li; Xiaolin Liang; Ting Yu; Peihong Shen; Haiyan Su; Jidong Liu; Hongcang Gu; Mouming Zhao; Quanyang Li
Journal:  Curr Microbiol       Date:  2015-03-25       Impact factor: 2.188

2.  Diversity of intestinal bifidobacteria in patients with Japanese cedar pollinosis and possible influence of probiotic intervention.

Authors:  Akira Kubota; Fang He; Manabu Kawase; Gaku Harata; Masaru Hiramatsu; Hisakazu Iino
Journal:  Curr Microbiol       Date:  2010-05-29       Impact factor: 2.188

Review 3.  Manipulating Microbiota to Treat Atopic Dermatitis: Functions and Therapies.

Authors:  Md Jahangir Alam; Liang Xie; Yu-Anne Yap; Francine Z Marques; Remy Robert
Journal:  Pathogens       Date:  2022-06-02

4.  The Difference of Gut Microbiota and Their Correlations With Urinary Organic Acids Between Autistic Children With and Without Atopic Dermatitis.

Authors:  Ru-Ping Hong; Yue-Ying Hou; Xin-Jie Xu; Ji-Dong Lang; Yun-Feng Jin; Xiao-Feng Zeng; Xuan Zhang; Geng Tian; Xin You
Journal:  Front Cell Infect Microbiol       Date:  2022-06-21       Impact factor: 6.073

5.  Intestinal microbiota in human health and disease: the impact of probiotics.

Authors:  Jacoline Gerritsen; Hauke Smidt; Ger T Rijkers; Willem M de Vos
Journal:  Genes Nutr       Date:  2011-05-27       Impact factor: 5.523

6.  The ProPrems trial: investigating the effects of probiotics on late onset sepsis in very preterm infants.

Authors:  Suzanne M Garland; Jacinta M Tobin; Marie Pirotta; Sepehr N Tabrizi; Gillian Opie; Susan Donath; Mimi L K Tang; Colin J Morley; Leah Hickey; Linh Ung; Susan E Jacobs
Journal:  BMC Infect Dis       Date:  2011-08-04       Impact factor: 3.090

Review 7.  Probiotics in the treatment and prevention of allergies in children.

Authors:  Erkki Savilahti
Journal:  Biosci Microflora       Date:  2011-11-17

8.  Probiotics in the treatment and prevention of allergy in children.

Authors:  Erkki Savilahti; Kaarina Kukkonen; Mikael Kuitunen
Journal:  World Allergy Organ J       Date:  2009-05       Impact factor: 4.084

9.  Perinatal maternal administration of Lactobacillus paracasei NCC 2461 prevents allergic inflammation in a mouse model of birch pollen allergy.

Authors:  Irma Schabussova; Karin Hufnagl; Mimi L K Tang; Elisabeth Hoflehner; Angelika Wagner; Gerhard Loupal; Sophie Nutten; Adrian Zuercher; Annick Mercenier; Ursula Wiedermann
Journal:  PLoS One       Date:  2012-07-06       Impact factor: 3.240

10.  Treating infant colic with the probiotic Lactobacillus reuteri: double blind, placebo controlled randomised trial.

Authors:  Valerie Sung; Harriet Hiscock; Mimi L K Tang; Fiona K Mensah; Monica L Nation; Catherine Satzke; Ralf G Heine; Amanda Stock; Ronald G Barr; Melissa Wake
Journal:  BMJ       Date:  2014-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.